ODTX
Odyssey Therapeutics, Inc.
18.10$
+0.2%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 24 | Q1 25 | Q2 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|
| -1,953.7% | -2,013.6% | -3,572.6% | – | – | |
| 73.7% | 67.7% | 132.1% | – | – | |
| 151.8% | 155.8% | 385.6% | – | – | |
| -144.9% | -275.5% | 252.6% | – | – | |
| 15.1% | 48.3% | 3.0% | – | – | |
| – | -1.8% | -3.6% | – | – | |
| 388.5% | 10.4% | 12,379.9% | – | – | |
| 1,122.6% | -220.3% | 11,271.1% | – | – | |
| -1,968.8% | -2,061.9% | -3,575.6% | – | – |
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.